Efficacy and Safety of SGLT2 Inhibitors in Type 1 Diabetes after the Introduction of an Off-Label Use Protocol for Clinical Practice

  1. Bayona Cebada, A.
  2. Nattero-Chávez, L.
  3. Alonso Díaz, S.
  4. Escobar-Morreale, H.F.
  5. Luque-Ramírez, M.
Aldizkaria:
Diabetes Technology and Therapeutics

ISSN: 1557-8593,  1520-9156

Argitalpen urtea: 2020

Alea: 22

Zenbakia: 3

Orrialdeak: 208-215

Mota: Artikulua

DOI: 10.1089/DIA.2019.0316 GOOGLE SCHOLAR
Datuen iturria: Scopus